Insiders · AKYA

Brian McKelligon

President and CEO, Director at Akoya Biosciences, Inc. (AKYA) since April 2021

Brian McKelligon has filed 22 insider reports with the SEC since April 2021, as president and CEO and director at Akoya Biosciences, Inc. (AKYA). Brian McKelligon made no open-market purchases or sales in the last 12 months. The latest filing, on July 11, 2025, reports shares withheld for taxes or exercise price and other acquisition or disposition at Akoya Biosciences, Inc. (AKYA).

Filings
22
Companies
1
Bought on market
None
Sold on market
$458K

Companies where Brian McKelligon is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Akoya Biosciences, Inc. logo
AKYA
Akoya Biosciences, Inc.
President and CEO, Directorsince April 20210$458KJul 11, 2025

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Brian McKelligon with

Other insiders at the same companies

Questions about Brian McKelligon

What is Brian McKelligon's role at Akoya Biosciences, Inc.?
Brian McKelligon reports to the SEC as president and CEO and director at Akoya Biosciences, Inc. (AKYA), according to the latest filing on July 11, 2025.
Has Brian McKelligon bought or sold stock recently?
The most recent open-market sale was on June 11, 2024: sold 7,500 shares of Akoya Biosciences, Inc. (AKYA) for $15.6K at an average of $2.08.
How do I get alerts when Brian McKelligon files?
Follow Brian McKelligon on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Brian McKelligon (SEC CIK 0001857447). Totals count each trade once, skipping amendments whose original is on file, from Apr 20, 2021 on. View on SEC EDGAR · Get this as JSON